Condition
Recurrent Follicular Lymphoma clinical trials and research
As of November 12, 2026, Find a Trial lists 4 Recurrent Follicular Lymphoma clinical trials that are recruiting, in United States. By phase: Phase 2 (2), Phase 1 (2). Every study is explained in plain English. Data from ClinicalTrials.gov and NIH RePORTER, updated November 12, 2026.
- 4Clinical trials
- 1Country
Newest Recurrent Follicular Lymphoma clinical trials
| Study | Phase | Where | Status | Registered |
|---|---|---|---|---|
| Pirtobrutinib plus Mosunetuzumab for relapsed or refractory grade 1–3a follicular lymphoma | Phase 2 | Seattle, Washington | Recruiting | Apr 29, 2025 |
| Q702 to treat blood cancers | Phase 1 | Scottsdale, Arizona and 1 other locations | Recruiting | Dec 2, 2024 |
| Treatment using modified T-cells for relapsed or refractory B-cell cancers | Phase 1 | Jacksonville, Florida | Recruiting | Jan 5, 2024 |
| Combining brentuximab vedotin and bendamustine for treating relapsed or refractory follicular lymphoma | Phase 2 | Sacramento, California | Recruiting | Oct 14, 2020 |
All recruiting trials (4)
-
Pirtobrutinib plus Mosunetuzumab for relapsed or refractory grade 1–3a follicular lymphoma
This trial tests whether giving pirtobrutinib together with mosunetuzumab can better treat adults with relapsed or refractory grade 1–3a follicular lymphoma.
-
Q702 to treat blood cancers
This Phase 1 trial will test whether the oral drug Q702 is safe, tolerable, and what dose works best for adults with certain blood cancers who have failed or are not eligible for standard treatments.
-
Treatment using modified T-cells for relapsed or refractory B-cell cancers
This study is testing a new treatment that uses specially modified T-cells to see if it can help people with hard-to-treat B-cell cancers.
-
Combining brentuximab vedotin and bendamustine for treating relapsed or refractory follicular lymphoma
This study is testing if combining two drugs, brentuximab vedotin and bendamustine, can help people with relapsed or hard-to-treat follicular lymphoma feel better and improve their chances of recovery.
Related topics
Quick answers
How many Recurrent Follicular Lymphoma clinical trials are recruiting right now?
4, as of November 12, 2026. We update this list each time we refresh our data from ClinicalTrials.gov.
Where are these trials running?
All of them have sites in United States. Each study page lists its sites and which ones are recruiting.
What phases are they in?
Phase 2: 2, Phase 1: 2. Trials with no phase listed are usually device, behavioural or observational studies.
How do I join one?
Open a study, check the "Is this trial a fit for you?" section, then contact the study team listed on the page. They will ask a few screening questions. Asking is free and does not commit you to anything. Talk it over with your doctor first.
Find the studies that fit you
A list is a starting point. Tell us your situation in your own words and we'll rank the studies that match and explain why. It's free and needs no account.